Bayer makes $62 billion cash offer for Monsanto


On Monday, Bayer AG formally unveiled a $62 billion offer for U.S. agribusiness giant Monsanto, offering a 37 percent premium over Monsanto's share price on May 9, the day before Bayer first disclosed its interest in the U.S. company. If completed, the all-cash deal would be the largest foreign acquisition by a German firm. "This transaction represents a compelling opportunity for Monsanto's shareholders," new Bayer CEO Werner Baumann argued in a conference call, providing investors "immediate and certain value." Bayer said it would finance the deal through selling shares and borrowing.
Bayer is better known as a pharmaceutical company, but it also makes pesticides, and buying Monsanto would makes its agricultural revenue roughly equal to its drug business, according to European investment bank Bryan Garner. Bayer focuses on agricultural chemicals, while Monsanto is best known for seeds. Not everyone approves of the proposed takeover, The Wall Street Journal notes. Some investors and analysts are worried that taking on so much debt would hurt Bayer's core pharmaceutical business, while others expressed concerns that buying Monsanto, the world's largest producer of genetically modified crops, would hurt Bayer's reputation, especially in anti-GMO Europe.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Violent videos of Charlie Kirk’s death are renewing debate over online censorship
Talking Points Social media ‘promises unfiltered access, but without guarantees of truth and without protection from harm’
-
What led to Poland invoking NATO’s Article 4 and where could it lead?
TODAY'S BIG QUESTION After a Russian drone blitz, Warsaw’s rare move to invoke the important NATO statute has potentially moved Europe closer to continent-wide warfare
-
Africa could become the next frontier for space programs
The Explainer China and the US are both working on space applications for Africa
-
New York court tosses Trump's $500M fraud fine
Speed Read A divided appeals court threw out a hefty penalty against President Trump for fraudulently inflating his wealth
-
Trump said to seek government stake in Intel
Speed Read The president and Intel CEO Lip-Bu Tan reportedly discussed the proposal at a recent meeting
-
US to take 15% cut of AI chip sales to China
Speed Read Nvidia and AMD will pay the Trump administration 15% of their revenue from selling artificial intelligence chips to China
-
NFL gets ESPN stake in deal with Disney
Speed Read The deal gives the NFL a 10% stake in Disney's ESPN sports empire and gives ESPN ownership of NFL Network
-
Samsung to make Tesla chips in $16.5B deal
Speed Read Tesla has signed a deal to get its next-generation chips from Samsung
-
FCC greenlights $8B Paramount-Skydance merger
Speed Read The Federal Communications Commission will allow Paramount to merge with the Hollywood studio Skydance
-
A potential railway megamerger raises monopoly questions
The Explainer Union Pacific and Norfolk Southern would create the country's largest railway operator
-
Tesla reports plummeting profits
Speed Read The company may soon face more problems with the expiration of federal electric vehicle tax credits